Unique Probiotics Formulation for Nutrition
Triple Care: Skin Moisture, Antioxidant, and Gut Health
Seoul—Cell Biotech's 'DUOLAB' announced the launch of the 'DUOLAB Synergy Beauty Pack' on the 28th, a new product designed to promote both inner beauty and gut health with just one pack a day. The standout feature of this product is its ability to increase the intestinal absorption rate by 149% when 'Hyaluronic Acid' is taken in combination with CELL BIOTECH probiotics.
Hyaluronic Acid, widely used in health supplements due to its ability to attract more than 1,000 times its weight in water, helps with skin moisture but has limited absorption due to its large molecular structure. The new product was developed by the 'CELL BIOTECH Microbiome Research Center,' which has been studying the relationship between the microbiome and human health for 29 years, addressing the challenges in absorption.
DUOLAB Synergy Beauty Pack
[Photo=Cell Biotech]
The unique probiotic formulations included in the new 'DUOLAB Synergy Beauty Pack'—CBT-ST3 (KCTC 11870BP), CBT-LP3 (KCTC 10782BP), CBT-LA1 (KCTC 11906BP), and CBT-LR5 (KCTC 12202BP)—break down Hyaluronic Acid into a low-molecular form, boosting intestinal absorption by an average of 149%. Notably, three of the probiotic strains have been found to produce Hyaluronic Acid on their own.
The DUOLAB Synergy Beauty Pack provides triple care—skin moisture, antioxidant, and gut health—with just one pack a day. It contains 120mg (100%) of the world's top premium Hyaluronic Acid, 5,000μg (16,667%) of Biotin to support energy production, 100mg (100%) of UK-sourced Vitamin C for antioxidant support, and 7 billion CFU of the four custom nutrition probiotics.
Additionally, the product is blended with eight other ingredients that support skin health, including Glutathione, Green Tea Extract, Fish Collagen, and an Amino Acid Complex.
Sung Joong-yong, Head of Marketing at Cell Biotech's DUOLAB, stated, "We were the first to propose and develop 'Unique probiotics formulation', which enhance the absorption of nutritional supplements when taken together with probiotics. We hope this new product will provide consumers with an easy and convenient way to experience a new level of inner beauty."
Meanwhile, in March, Cell Biotech took a significant step forward in becoming a biopharmaceutical company by developing the differentiated R&D-backed microbiome colorectal cancer drug 'PP-P8,' which received approval for a Phase 1 clinical trial (IND).